ReviewDrugs2020

Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer.

Katherine A Lyseng-WilliamsonPubMed ↗Publisher ↗

No numbers read from the abstract.